Canopy Growth (TSE:WEED – Get Free Report) has been given a C$2.00 price objective by research analysts at Canaccord Genuity Group in a research report issued on Friday,BayStreet.CA reports. The firm presently has a “speculative buy” rating on the stock. Canaccord Genuity Group’s price target would suggest a potential upside of 60.00% from the company’s current price.
Several other equities research analysts have also recently issued reports on the company. Sanford C. Bernstein cut their target price on Canopy Growth from C$5.30 to C$2.50 in a research note on Wednesday, January 14th. ATB Cormark Capital Markets raised Canopy Growth from a “sector perform” rating to an “outperform” rating and set a C$1.40 price target on the stock in a research note on Tuesday, March 17th. Two analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of C$1.97.
Check Out Our Latest Stock Report on Canopy Growth
Canopy Growth Price Performance
Canopy Growth (TSE:WEED – Get Free Report) last announced its quarterly earnings results on Friday, February 6th. The company reported C($0.18) earnings per share (EPS) for the quarter. The firm had revenue of C$74.54 million for the quarter. Canopy Growth had a negative return on equity of 52.88% and a negative net margin of 117.31%. As a group, analysts anticipate that Canopy Growth will post -0.69 EPS for the current year.
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.
Featured Stories
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.
